Subscribe


PD breaking news – Actavis to exit Australian generics

Allergan Australia and New Zealand acquisition completed. 

Actavis has confirmed it will exit the Australian generics business, as part of the completed acquisition of Allergan Australia and New Zealand.

This included the generic hospital, generic pharmaceutical, Pierre Fabre and Medico businesses.

“In the interim, Actavis will continue to supply the Australian market with high quality generic medicines through its current distribution channels while alternative distribution models are actively explored.”

The Actavis New Zealand generic market would continue with no change.

Actavis would also seek shareholder approval to change its name to Allergan in May or June, although the Actavis name could continue to be used for certain regions and products, Allergan said.

Allergan ANZ vice president and md Glen Curran said it was “very much business as usual” and in the short term, the company was working to integrate the companies smoothly.

“During this process we are committed to keeping all of our customers informed of our progress.”

The combined company would offer an expanded portfolio of innovator products, Allergan said.

Curran said about $1.7b would be invested globally in R&D this year.

For more, see tomorrow’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Mar 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

22 Aug

Guild Update 22 Aug 17: Clear information on medicines - THE Therapeutic Goods Administration has introduced improvements ...


22 Aug

Dispensary Corner 22 Aug 17 - WHITE supremacists in the USA are somewhat ...


22 Aug

Liptember support - CHEMIST Warehouse is once again sponsoring the ...


22 Aug

Gardasil-9 for NIP - THE Pharmaceutical Benefits Advisory committee (PBAC) has ...


22 Aug

Private in public hospitals - THE Australian Federal Government Department of Health ...


22 Aug

VPA appointment - THE Victorian Pharmacy Authority has confirmed the ...


22 Aug

Bronchitol PBAC tick - LISTED pharmaceutical research firm Pharmaxis has welcomed ...


22 Aug

Pharmacy first for pain - SANOFI Consumer Healthcare has released new research ...


22 Aug

Monash pharmacy EDGE - THE Faculty of Pharmacy and Pharmaceutical Sciences ...


21 Aug

Weekly Comment 21 Aug 17: Don’t burn your bridges – Part 1 - This week's contributor is Amy Filicietti, Recruitment ...


21 Aug

Dispensary Corner 21 Aug 17 - THERE'S been a major fake tan fail ...


21 Aug

Healthscope sells medical centres - HEALTHSCOPE Limited on Fri confirmed the $55 ...


21 Aug

Generic orlistat - ARROW Pharma has announced the launch of ...


21 Aug

CW stocks SASMAR - SASMAR has announced that its Conceive Plus ...


21 Aug

Connect with CPD - NEXT week's Pharmacy Connect conference at the ...


21 Aug

JPPR vulnerable focus - THE latest issue of the flagship publication ...


21 Aug

Fake meds webinar - THE International Pharmaceutical Federation (FIP) has announced ...


21 Aug

30% pharmacist pay rise push - PROFESSIONAL Pharmacists Australia has launched a campaign ...


21 Aug

Practice guidelines revised - THE Pharmaceutical Society of Australia (PSA) has ...


18 Aug

Events Calendar 18 Aug 17 - 1-3 Sep: Pharmacy Connect; Hilton Hotel Sydney; ...



Show Pharmacy Daily items by month: